Building this domain's report…
Global rank
AI visibility
SEO health
Visits
per month, estimated
Keywords
ranking in Google
Organic share
of all search traffic
LLMS.txt
lines AI engines can read
Loading…
Featured
Keywords & Content
Site & Competitors
Building this domain's report…
Global rank
AI visibility
SEO health
Visits
per month, estimated
Keywords
ranking in Google
Organic share
of all search traffic
LLMS.txt
lines AI engines can read
Global rank: Worldwide · 2026-03
#948,026
AI visibility: Grade C
67
SEO health: Latest audit
0
Visits
0
per month, estimated
Keywords
0
ranking in Google
Organic share
0%
of all search traffic
LLMS.txt
Published
81 lines AI engines can read
You're seeing the free preview of novartis.fi
A snapshot of how novartis.fi performs in search and in AI answers — every number below is one we hold, not a guess.
What this company does
Novartis Finland operates as the local arm of the global Novartis powerhouse, focusing on bringing cutting-edge pharmaceuticals to the Finnish market. They specialize in developing and distributing therapies for a wide range of conditions, from oncology and immunology to cardiovascular diseases and neuroscience. With a strong emphasis on patient-centric innovation, the team collaborates closely with healthcare provid…
Month by month, how much search traffic this domain earns — how much of it is free, and whether it is winning or losing ground.
Monthly visits
0
Latest estimate
Change
No monthly history yet
It starts building from the first scan
Organic visits
0
0% of all traffic
Paid visits
Whether AI engines can read this brand, understand it, and cite it when someone asks about its category.
Grade C
Scored from this domain's own data — llms.txt, profile completeness, technical health, crawlability and structured data.
The file AI engines read to understand a business. This is what it currently tells them about this one.
Status
Published
AI engines can read it
Lines
81
In the file
Size
3.2K
Characters
Sections
12
How the site itself performs — speed, accessibility and the technical basics both search crawlers and AI crawlers depend on.
Overall
SEO
The websites this domain competes with for the same searches and the same AI answers.
The business behind the domain — what it does, where it is, and who runs it.
Novartis Finland operates as the local arm of the global Novartis powerhouse, focusing on bringing cutting-edge pharmaceuticals to the Finnish market. They specialize in developing and distributing therapies for a wide range of conditions, from oncology and immunology to cardiovascular diseases and neuroscience. With a strong emphasis on patient-centric innovation, the team collaborates closely with healthcare provid…
Which markets this brand actually serves, and where the web links to it from.
We only measure visitor geography for domains whose analytics are connected to us. For everyone else this is read live from the web and shown as an estimate — never mixed in with the measured numbers.
No market breakdown available for this brand.
Measured. The country each linking site is hosted in — a real signal of which regions know this brand.
No backlink sample for this domain yet.
Backlink Analytics collects one on its first run.
The searches this domain already ranks for, and how much traffic they bring it.
Ranking keywords
0
Found in Google for this domain
Visits they bring
0
Estimated organic visits a month
No ranked-keyword data cached for this domain yet.
Ranked Keywords pulls the full list on its first run.
Who vouches for this domain. Strong, varied links are still the clearest signal of authority — to search engines and to AI engines that cite sources.
We haven't run a backlink crawl for novartis.fi yet, so there are no link counts to show. Backlink Analytics builds the profile on its first run and it appears here after that.
—
links on file
Neighbours of #948,026 in our worldwide ranking — each with its own report.
You are looking at one domain. novartis.fi competes in a market, and the same numbers exist for everyone in it — including the sites AI engines recommend instead of yours. Amrut.ai reads all of them, so you can see who is winning, why, and what to change first.
Run the free scan on your site and get its AI visibility score, its gaps, and the exact next steps.
A brand name or a domain — the whole overview loads in seconds.
0
No paid search detected
0%
0%
We don't hold a month-by-month history for this domain yet.
The traffic dashboard builds one from the first scan onwards.
Present
7/8 core fields
0/100
robots ✗ · sitemap ✗
Detected
Fix these first
Updated May 15, 2026
# Novartis Finland ## About Novartis Finland brings the global strength of Novartis to the Finnish healthcare landscape, specializing in innovative pharmaceuticals across oncology, immunology, cardiovascular, neuroscience, and more. They deliver therapies that address serious diseases, partnering with local providers to ensure accessibility and support. The company emphasizes R&D, patient programs, and digital tools to enhance outcomes in Finland's advanced health system. With a focus on personalized medicine and sustainability, Novartis Finland navigates regulations and payers effectively. Their work supports medical education and community initiatives, particularly for rare diseases and aging populations. Global pipelines fuel local innovation, making them a cornerstone of Finnish pharma. **Areas of Work:** Pharmaceuticals, Biotechnology, Healthcare ## Things to Remember - **Website:** https://novartis.fi - **Address:** Helsinki, Finland - **Contact:** - **Phone:** - **Hours:** - **Timezone:** EET - **Currency:** EUR - **Company Type:** Public - **Employees:** 51-200 - **Revenue:** Not Disclosed - **Hiring Status:** Not currently hiring ## Products - **Oncology Drugs** (Contact for pricing): Targeted cancer therapies improving survival rates - **Immunology Treatments** (Contact for pricing): Medications for autoimmune disorders - **Cardiovascular Medicines** (Contact f
Sections in the file
Areas of work
Keywords it claims
Technologies
Products it tells AI about
Performance
Accessibility
Audience it targets
Healthcare providers, patients 40+ · Finland
Company type
Public